Cargando…
The Societal Value of Broader Access to Antiobesity Medications
OBJECTIVE: Obesity and its complications place an enormous burden on society. Yet antiobesity medications (AOM) are prescribed to only 2% of the eligible population, even though few individuals can sustain weight loss using other strategies alone. This study estimated the societal value of greater a...
Autores principales: | Kabiri, Mina, Sexton Ward, Alison, Ramasamy, Abhilasha, van Eijndhoven, Emma, Ganguly, Rahul, Smolarz, B. Gabriel, Zvenyach, Tracy, Goldman, Dana P., Baumgardner, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003734/ https://www.ncbi.nlm.nih.gov/pubmed/31869002 http://dx.doi.org/10.1002/oby.22696 |
Ejemplares similares
-
Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy
por: Kabiri, Mina, et al.
Publicado: (2021) -
Direct medical costs of obesity in the United States and the most populous states
por: Cawley, John, et al.
Publicado: (2021) -
Societal Impacts and Broader Implications of Using Technologies for Caregiving
por: D’Ambrosio, Lisa, et al.
Publicado: (2020) -
Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial
por: Pantalone, Kevin M., et al.
Publicado: (2021) -
Reporting health services research to a broader public: An exploration of inconsistencies and reporting inadequacies in societal publications
por: Gerrits, Reinie G., et al.
Publicado: (2021)